Transcatheter Mitral and Tricuspid Valve Repair: Advances and Challenges

Dear Colleagues,

Mitral regurgitation is the most common valvular abnormality, thought to affect over 2% of the world population, and is the second most frequent indication for valve surgery, following aortic stenosis. Data concerning tricuspid regurgitation is limited, but we know that this “forgotten valve” has immense independent impact on patient prognosis. Advancements in the diagnosis, medical management, and percutaneous therapy of both mitral and tricuspid regurgitation in recent years have completely changed the way we are able to manage these patients. However, there is much yet to learn on the future of transcatheter mitral and tricuspid valve repair.

We are very excited to serve as the Guest Editors for a Special Issue of the Journal of Clinical Medicine and invite you to submit novel research publications related to transcatheter therapies of both mitral and tricuspid regurgitation. We would like to invite state-of-the-art reviews as well as original research articles in this area to be considered for inclusion in this Issue. Such manuscripts could focus on the identification of mitral and tricuspid regurgitation, risk stratification, the interventional treatment methods and outcomes (with special focus on novel technologies), medical therapy before and after intervention, and more.

Dr. Leor Perl
Dr. Rodrigo Estévez-Loureiro
Dr. Xavier Freixa
Dr. Dabit Arzamendi
Dr. Dan Haberman
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.